Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue

Stroke

Volumn 34, Issue 6, 2003, Pages 1425-1430

  Shih, Ludy C ^a,d   Saver, Jeffrey L ^a,b   Alger, Jeffry R ^a,b   Starkman, Sidney ^a,b   Leary, Megan C ^a,b   Vinuela, Fernando ^a,b   Duckwiler, Gary ^a,b   Gobin, Y Pierre ^c   Jahan, Reza ^a,b   Villablanca, J Pablo ^a,b   Vespa, Paul M ^a,b   Kidwell, Chelsea S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c New York Presbyterian Veterans Administration   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Magnetic resonance imaging, perfusion weighted; Stroke, acute; Stroke, ischemic; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; LINEAR REGRESSION ANALYSIS; MALE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; DISEASE PROGRESSION; DRUG ADMINISTRATION ROUTES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0038460314     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000072998.70087.E9     Document Type: Article

References (27)

1. NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
3. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283:1151-1158.
4. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, Yatsu FM, Grotta JC. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18-22.
5. Nilasena DS, Kresowik TF, Wiblin RT, Piskac AF, Kresowik RA, Brenton MA, Wilwert JM, Hendel ME. Assessing patterns of tPA use in acute stroke. Stroke. 2002;33:354. Abstract.
6. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke [published erratum appears in Neurology. 1992;42:2192]. Neurology. 1992;42:1717-1723.
7. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Mödder U, Freund HJ. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke. 1999;30:1591-1597.
8. Grandin CB, Duprez TP, Smith AM, Mataigne F, Peeters A, Oppenheim C, Cosnard G. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke. 2001;32:1147-1153.
9. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587.
10. Rose SE, Chalk JB, Griffin MP, Janke AL, Chen F, McLachan GJ, Peel D, Zelaya FO, Markus HS, Jones DK, et al. MRI based diffusion and perfusion predictive model to estimate stroke evolution. Magn Reson Imaging. 2001;19:1043-1053.
11. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
12. Wittsack HJ, Ritzl A, Fink GR, Wenserski F, Siebler M, Seitz RJ, Modder U, Freund HJ. MR Imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology. 2002;222:397-403.
13. Schlaug G, Benfield A, Baird AE, Siewert B, Lovblad KO, Parker RA, Edelman RR, Warach S. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
14. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
15. Uno M, Harada M, Okada T, Nagahiro S. Diffusion-weighted and perfusion-weighted magnetic resonance imaging to monitor acute intra-arterial thrombolysis. J Stroke Cerebrovasc Dis. 2000;9:113-120.
16. Lutsep HL, Nesbit GM, Berger RM, Coshow WR. Does reversal of ischemia on diffusion-weighted imaging reflect higher apparent diffusion coefficient values? J Neuroimaging. 2001;11:313-316.
17. Chalela JA, Ezzeddine MA, Calabrese TM, Latour LM, Baird AE, Luby ML, Warach S. Diffusion and perfusion changes two hours after intra-venous rt-PA therapy: a preliminary report. Stroke. 2002;33:356-357.
18. Heiss WD, Grond M, Thiel A, von Stockhausen HM, Rudolf J, Ghaemi M, Lottgen J, Stenzel C, Pawlik G. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab. 1998;18:1298-1307.
19. Marchal G, Benali K, Iglesias S, Viader F, Derlon JM, Baron JC. Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke. Brain. 1999;122(pt 12):2387-2400.
20. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intra-venous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
21. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part I: mathematical approach and statistical analysis. Magn Reson Med. 1996;36:715-725.
22. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226.
23. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999;19:701-735.
24. Kidwell CS, Alger JR, Saver JL, Mattiello JH, Woods RP, Starkman SS, Liebeskind DS, Vespa PM, Jahan R, Gobin YP, et al. MR signatures of infarction vs. salvageable penumbra in acute human stroke: a preliminary model. Stroke. 2000;31:285. Abstract.
25. Kidwell CS, Saver JL, Mattiello J, Alger J, Sayre J, for the UCLA MRI Thrombolysis Investigators. A diffusion-perfusion MRI signature predicting hemorrhagic transformation following intra-arterial thrombolysis. Stroke. 2000;31:318. Abstract.
26. Wu O, Koroshetz WJ, Ostergaard L, Buonanno FS, Copen WA, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Sorensen AG. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke. 2001;32:933-942.
27. Jacobs MA, Mitsias P, Soltanian-Zadeh H, Santhakumar S, Ghanei A, Hammond R, Peck DJ, Chopp M, Patel S. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: part 2. Stroke. 2001;32:950-957.